{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:55:12Z","timestamp":1790834112172,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"Paulon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Hematology Association"},{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007788","name":"Blood Disease Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lasten sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6 V\u00e4re, Finland"},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["322675"],"award-info":[{"award-number":["322675"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["137680"],"award-info":[{"award-number":["137680"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Finnish Special Governmental Subsidy for Health Sciences, Research, and Training"},{"name":"the Helsinki University Hospital Comprehensive Cancer Research Funding"},{"DOI":"10.13039\/501100003406","name":"Tekes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iCAN Digital Precision Cancer Medicine"},{"DOI":"10.13039\/501100004325","name":"Signe ja Ane Gyllenbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite recent progress in acute lymphoblastic leukemia (ALL) therapies, a significant subset of adult and pediatric ALL patients has a dismal prognosis. Better understanding of leukemogenesis and recognition of germline genetic changes may provide new tools for treating patients. Given that hematopoietic stem cell transplantation, often from a family member, is a major form of treatment in ALL, acknowledging the possibility of hereditary predisposition is of special importance. Reports of comprehensive germline analyses performed in adult ALL patients are scarce. Aiming at fulfilling this gap of knowledge, we investigated variants in 93 genes predisposing to hematologic malignancies and 70 other cancer-predisposing genes from exome data obtained from 61 adult and 87 pediatric ALL patients. Our results show that pathogenic (P) or likely pathogenic (LP) germline variants in genes associated with predisposition to ALL or other cancers are prevalent in ALL patients: 8% of adults and 11% of children. Comparison of P\/LP germline variants in patients to population-matched controls (gnomAD Finns) revealed a 2.6-fold enrichment in ALL cases (CI 95% 1.5\u20134.2,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.00071). Acknowledging inherited factors is crucial, especially when considering hematopoietic stem cell transplantation and planning post-therapy follow-up. Harmful germline variants may also predispose patients to excessive toxicity potentially compromising the outcome. We propose integrating germline genetics into precise ALL patient care and providing families genetic counseling.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-14364-x","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T10:03:37Z","timestamp":1655978617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"12","author":[{"given":"Suvi P. M.","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atte K.","family":"Lahtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Koski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilli","family":"Leimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko A. I.","family":"Ker\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Koskenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Pitk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Wartiovaara-Kautto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kilpivaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"14364_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft, N. et al. Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia 32, 606\u2013615 (2018).","journal-title":"Leukemia"},{"key":"14364_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood.2019004043","volume":"136","author":"SP Hunger","year":"2020","unstructured":"Hunger, S. P. & Raetz, E. A. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood 136, 1803\u20131812 (2020).","journal-title":"Blood"},{"key":"14364_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","volume":"2018","author":"KG Roberts","year":"2018","unstructured":"Roberts, K. G. Genetics and prognosis of ALL in children vs adults. Hematology 2018, 137\u2013145 (2018).","journal-title":"Hematology"},{"key":"14364_CR4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard, F. & Mohty, M. Acute lymphoblastic leukaemia. Lancet 395, 1146\u20131162 (2020).","journal-title":"Lancet"},{"key":"14364_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132406 (2016).","journal-title":"Blood"},{"key":"14364_CR6","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41375-018-0049-5","volume":"32","author":"U Wartiovaara-Kautto","year":"2018","unstructured":"Wartiovaara-Kautto, U. et al. Germline alterations in a consecutive series of acute myeloid leukemia. Leukemia 32, 2282\u20132285 (2018).","journal-title":"Leukemia"},{"key":"14364_CR7","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.1038\/s41598-021-88449-4","volume":"11","author":"S-Y Shin","year":"2021","unstructured":"Shin, S.-Y. et al. Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients. Sci. Rep. 11, 8893 (2021).","journal-title":"Sci. Rep."},{"key":"14364_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","volume":"33","author":"ML Churchman","year":"2018","unstructured":"Churchman, M. L. et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell 33, 937-948.e8 (2018).","journal-title":"Cancer Cell"},{"key":"14364_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/leu.2013.363","volume":"28","author":"F Auer","year":"2014","unstructured":"Auer, F. et al. Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A. Leukemia 28, 1136\u20131138 (2014).","journal-title":"Leukemia"},{"key":"14364_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ng.2754","volume":"45","author":"S Shah","year":"2013","unstructured":"Shah, S. et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat. Genet. 45, 1226\u20131231 (2013).","journal-title":"Nat. Genet."},{"key":"14364_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","volume":"16","author":"T Moriyama","year":"2015","unstructured":"Moriyama, T. et al. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: A systematic genetic study. Lancet Oncol. 16, 1659\u20131666 (2015).","journal-title":"Lancet Oncol."},{"key":"14364_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1005262","volume":"11","author":"S Topka","year":"2015","unstructured":"Topka, S. et al. Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia. PLoS Genet. 11, 1\u201314 (2015).","journal-title":"PLoS Genet."},{"key":"14364_CR13","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba, H. & Mullighan, C. G. Pediatric acute lymphoblastic leukemia. Haematologica 105, 2524\u20132539 (2020).","journal-title":"Haematologica"},{"key":"14364_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/blood.2018852400","volume":"134","author":"Y Gocho","year":"2019","unstructured":"Gocho, Y. & Yang, J. J. Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia. Blood 134, 793\u2013797 (2019).","journal-title":"Blood"},{"key":"14364_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ng.432","volume":"41","author":"LR Trev\u0129o","year":"2009","unstructured":"Trev\u0129o, L. R. et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet. 41, 1001\u20131005 (2009).","journal-title":"Nat. Genet."},{"key":"14364_CR16","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/ng.2803","volume":"45","author":"V Perez-Andreu","year":"2013","unstructured":"Perez-Andreu, V. et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat. Genet. 45, 1494\u20131498 (2013).","journal-title":"Nat. Genet."},{"issue":"11","key":"14364_CR17","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1038\/s41375-019-0514-9","volume":"33","author":"AJ de Smith","year":"2019","unstructured":"de Smith, A. J. et al. Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without down syndrome. Leukemia 33(11), 2746\u20132751 (2019).","journal-title":"Leukemia"},{"key":"14364_CR18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/bjh.17477","volume":"193","author":"R R\u00f6nkk\u00f6","year":"2021","unstructured":"R\u00f6nkk\u00f6, R. et al. Familial aggregation of early-onset haematological malignancies. Br. J. Haematol. 193, 1134\u20131141 (2021).","journal-title":"Br. J. Haematol."},{"key":"14364_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.12069","volume":"159","author":"E Kharazmi","year":"2012","unstructured":"Kharazmi, E. et al. Familial risks for childhood acute lymphocytic leukaemia in Sweden and Finland: Far exceeding the effects of known germline variants. Br. J. Haematol. 159, 585\u2013588 (2012).","journal-title":"Br. J. Haematol."},{"key":"14364_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pbc.10461","volume":"42","author":"UM Saarinen-Pihkala","year":"2004","unstructured":"Saarinen-Pihkala, U. M. et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr. Blood Cancer 42, 8\u201323 (2004).","journal-title":"Pediatr. Blood Cancer"},{"key":"14364_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3324\/haematol.2015.131680","volume":"101","author":"T Oskarsson","year":"2016","unstructured":"Oskarsson, T. et al. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: Prognostic factors, treatment and outcome. Haematologica 101, 68\u201376 (2016).","journal-title":"Haematologica"},{"key":"14364_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/bjh.17247","volume":"194","author":"AM Trottier","year":"2021","unstructured":"Trottier, A. M. & Godley, L. A. Inherited predisposition to haematopoietic malignancies: Overcoming barriers and exploring opportunities. Br. J. Haematol. 194, 663\u2013676 (2021).","journal-title":"Br. J. Haematol."},{"key":"14364_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1200\/JCO.2016.70.8644","volume":"35","author":"E Furutani","year":"2017","unstructured":"Furutani, E. & Shimamura, A. Germline genetic predisposition to hematologic malignancy. J. Clin. Oncol. 35, 1018\u20131028 (2017).","journal-title":"J. Clin. Oncol."},{"key":"14364_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC cancer gene census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"14364_CR25","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/s41596-018-0052-3","volume":"13","author":"R Katainen","year":"2018","unstructured":"Katainen, R. et al. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer. Nat. Protoc. 13, 2580\u20132600 (2018).","journal-title":"Nat. Protoc."},{"key":"14364_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"14364_CR27","unstructured":"The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68\u201374 (2015)."},{"key":"14364_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"14364_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li, Q. & Wang, K. InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am. J. Hum. Genet. 100, 267\u2013280 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"14364_CR30","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos, C. et al. VarSome: The human genomic variant search engine. Bioinformatics 35, 1978 (2019).","journal-title":"Bioinformatics"},{"key":"14364_CR31","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"14364_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016)."},{"key":"14364_CR33","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (2021)."},{"key":"14364_CR34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa042980","volume":"352","author":"H Yamaguchi","year":"2005","unstructured":"Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in Aplastic Anemia. N. Engl. J. Med. 352, 1413\u20131424 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"D1","key":"14364_CR35","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46(D1), D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"14364_CR36","doi-asserted-by":"crossref","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"14364_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"14364_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","volume":"27","author":"SS Sahoo","year":"2021","unstructured":"Sahoo, S. S. et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes. Nat. Med. 27, 1806\u20131817 (2021).","journal-title":"Nat. Med."},{"key":"14364_CR39","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","volume":"132","author":"Y Nagata","year":"2018","unstructured":"Nagata, Y. et al. Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. Blood 132, 2309 (2018).","journal-title":"Blood"},{"key":"14364_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","volume":"4","author":"AL Brown","year":"2020","unstructured":"Brown, A. L. et al. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. Blood Adv. 4, 1131\u20131144 (2020).","journal-title":"Blood Adv."},{"key":"14364_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12185-010-0612-y","volume":"92","author":"N Nishimoto","year":"2010","unstructured":"Nishimoto, N. et al. T cell acute lymphoblastic leukemia arising from familial platelet disorder. Int. J. Hematol. 92, 194\u2013197 (2010).","journal-title":"Int. J. Hematol."},{"key":"14364_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/cge.13370","volume":"94","author":"G D\u2019Amours","year":"2018","unstructured":"D\u2019Amours, G. et al. Refining the phenotype associated with biallelic DNAJC21 mutations. Clin. Genet. 94, 252\u2013258 (2018).","journal-title":"Clin. Genet."},{"issue":"6","key":"14364_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/bjh.17855","volume":"196","author":"K Tawana","year":"2021","unstructured":"Tawana, K., Brown, A. L. & Churpek, J. E. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: Current strategies and challenges. Br. J. Haematol. 196(6), 1293\u20131310 (2021).","journal-title":"Br. J. Haematol."},{"key":"14364_CR44","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","volume":"373","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 373, 2336\u20132346 (2015).","journal-title":"N. Engl. J. Med."},{"key":"14364_CR45","doi-asserted-by":"publisher","first-page":"026286","DOI":"10.1101\/cshperspect.a026286","volume":"7","author":"EQ Comeaux","year":"2017","unstructured":"Comeaux, E. Q. & Mullighan, C. G. TP53 mutations in hypodiploid acute lymphoblastic leukemia. Cold Spring Harb. Perspect. Med. 7, 026286 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"14364_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejmg.2016.01.003","volume":"59","author":"H Cav\u00e9","year":"2016","unstructured":"Cav\u00e9, H. et al. Acute lymphoblastic leukemia in the context of RASopathies. Eur. J. Med. Genet. 59, 173\u2013178 (2016).","journal-title":"Eur. J. Med. Genet."},{"key":"14364_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ajmg.a.61445","volume":"182","author":"J Chinton","year":"2020","unstructured":"Chinton, J. et al. Providing more evidence on LZTR1 variants in Noonan syndrome patients. Am. J. Med. Genet. A 182, 409\u2013414 (2020).","journal-title":"Am. J. Med. Genet. A"},{"key":"14364_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","volume":"52","author":"GL Yamamoto","year":"2015","unstructured":"Yamamoto, G. L. et al. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J. Med. Genet. 52, 413\u2013421 (2015).","journal-title":"J. Med. Genet."},{"key":"14364_CR49","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","volume":"20","author":"JJ Johnston","year":"2018","unstructured":"Johnston, J. J. et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet. Med. 20, 1175\u20131185 (2018).","journal-title":"Genet. Med."},{"key":"14364_CR50","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/neuonc\/noy009","volume":"20","author":"C Louvrier","year":"2018","unstructured":"Louvrier, C. et al. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis. Neuro Oncol. 20, 917\u2013929 (2018).","journal-title":"Neuro Oncol."},{"key":"14364_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mrfmmm.2013.03.003","volume":"743\u2013744","author":"F Mazzei","year":"2013","unstructured":"Mazzei, F., Viel, A. & Bignami, M. Role of MUTYH in human cancer. Mutat. Res. Fundam. Mol. Mech. Mutagen. 743\u2013744, 33\u201343 (2013).","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"14364_CR52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/ERC-17-0196","volume":"24","author":"JP Dumanski","year":"2017","unstructured":"Dumanski, J. P. et al. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. Endocr. Relat. Cancer 24, 427\u2013443 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"14364_CR53","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/cncr.26506","volume":"118","author":"G Rennert","year":"2012","unstructured":"Rennert, G. et al. MutYH mutation carriers have increased breast cancer risk. Cancer 118, 1989\u20131993 (2012).","journal-title":"Cancer"},{"key":"14364_CR54","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1200\/JCO.2016.66.5844","volume":"34","author":"MK Schmidt","year":"2016","unstructured":"Schmidt, M. K. et al. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2\u22171100delC Carriers. J. Clin. Oncol. 34, 2750\u20132760 (2016).","journal-title":"J. Clin. Oncol."},{"key":"14364_CR55","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1200\/JCO.2015.63.3594","volume":"34","author":"C Naslund-Koch","year":"2016","unstructured":"Naslund-Koch, C., Nordestgaard, B. G. & Bojesen, S. E. Increased risk for other cancers in addition to breast cancer for CHEK2\u22171100delC heterozygotes estimated from the copenhagen general population study. J. Clin. Oncol. 34, 1208\u20131216 (2016).","journal-title":"J. Clin. Oncol."},{"key":"14364_CR56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391, 1023\u20131075 (2018).","journal-title":"Lancet"},{"issue":"11","key":"14364_CR57","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1038\/s41375-021-01246-w","volume":"35","author":"D Singhal","year":"2021","unstructured":"Singhal, D. et al. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia 35(11), 3245\u20133256 (2021).","journal-title":"Leukemia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14364-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:05:40Z","timestamp":1700741140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14364-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14364"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14364-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10670"}}